| Companies sponsors |
Eli Lilly (abemaciclib) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| |
NHS Vale of York CCG |
| |
NHS Hambleton, Richmondshire and Whitby CCG |
| |
Welsh Government |
| Patient carer groups |
Black Health Agency |
| |
Breast Cancer Now |
| |
Breast Cancer Haven |
| |
Breast Cancer UK |
| |
Cancer Black Care |
| |
Cancer Equality |
| |
Helen Rollason Cancer Charity |
| |
Independent Cancer Patients Voice |
| |
Macmillan Cancer Support |
| |
Maggie’s Centres |
| |
Marie Curie |
| |
South Asian Health Foundation |
| |
Specialised Healthcare Alliance |
| |
Tenovus Cancer Care |
| Professional groups |
Association of Anaesthetists |
| |
Association of Breast Surgery |
| |
Association of Cancer Physicians |
| |
Association of Surgeons of Great Britain & Ireland |
| |
British Association of Surgical Oncology |
| |
British Geriatrics Society |
| |
British Institute of Radiology |
| |
British Psychosocial Oncology Society |
| |
Cancer Research UK |
| |
Royal College of Anaesthetists |
| |
Royal College of General Practitioners |
| |
Royal College of Nursing |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| |
Royal College of Surgeons |
| |
Royal Pharmaceutical Society |
| |
Royal Society of Medicine |
| |
Society and College of Radiographers |
| |
UK Breast Cancer Group |
| |
UK Clinical Pharmacy Association |
| |
UK Oncology Nursing Society |
| Associated public health groups |
Public Health England |
| |
Public Health Wales |
| Comparator companies |
Accord Healthcare Limited (anastrozole, exemestane, letrozole) |
| |
Aurobindo Pharma (tamoxifen) |
| |
AstraZeneca UK Limited (anastrozole) |
| |
Cipla EU Ltd (letrozole) |
| |
Dr. Reddy’s Laboratories (UK) Ltd (letrozole) |
| |
Glenmark Pharmaceuticals Europe Ltd (exemestane, letrozole) |
| |
Mylan (anastrozole, exemestane, tamoxifen) |
| |
Novartis Pharmaceuticals UK Ltd (letrozole) |
| |
Pfizer Limited (exemestane) |
| |
Ranbaxy (UK) Limited a Sun Pharmaceutical Company (anastrozole, letrozole) |
| |
Rosemont Pharmaceuticals Limited (tamoxifen) |
| |
Sandoz Limited (anastrozole) |
| |
Tillomed Laboratories Ltd (tamoxifen) |
| |
Wockhardt UK Ltd (anastrozole, tamoxifen) |
| |
Zentiva (exemestane) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
Allied Health Professionals Federation |
| |
Board of Community Health Councils in Wales |
| |
British National Formulary |
| |
Care Quality Commission |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
National Association for Primary Care |
| |
National Pharmacy Association |
| |
NHS Alliance |
| |
NHS Commercial Medicines Unit |
| |
NHS Confederation |
| |
Scottish Medicines Consortium |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Against Breast Cancer |
| |
Breast Cancer Hope |
| |
Breast Cancer Research Trust |
| |
Cochrane Breast Cancer Group |
| |
Genomics England |
| |
Institute of Cancer Research |
| |
MRC Clinical Trials Unit |
| |
National Cancer Research Institute |
| |
National Cancer Research Network |
| |
National Institute for Health Research |
| |
Pro-Cancer Research Fund |